# Municipal Hirakata City Hospital

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/municipal-hirakata-city-hospital/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 105 |
| Citations | 24,499 |
| City | Osaka |
| Country | JP |
| Description | Municipal Hirakata City Hospital is a research organisation in Osaka, JP. OpenAlex records 890 works and 24,499 citations for it. 221 researchers list it as their most recent affiliation. |
| Homepage | http://hirakatacity-hp.osaka.jp/ |
| OpenAlex ID | https://openalex.org/I4210166362 |
| Researchers | 221 |
| ROR ID | https://ror.org/05wvk1430 |
| Type | healthcare |
| Works | 890 |

## University papers

Showing 12 of 18.

- [Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation](https://scholariq.org/papers/dual-antithrombotic-therapy-with-dabigatran-after-pci-in-atrial-fibrillation/)
- [Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis](https://scholariq.org/papers/stent-thrombosis-with-drug-eluting-and-bare-metal-stents-evidence-from-a/)
- [Predicting Successful Guidewire Crossing Through Chronic Total Occlusion of Native Coronary Lesions Within 30 Minutes](https://scholariq.org/papers/predicting-successful-guidewire-crossing-through-chronic-total-occlusion-of/)
- [Effect of 1-Month Dual Antiplatelet Therapy Followed by Clopidogrel vs 12-Month Dual Antiplatelet Therapy on Cardiovascular and Bleeding Events in Patients Receiving PCI](https://scholariq.org/papers/effect-of-1-month-dual-antiplatelet-therapy-followed-by-clopidogrel-vs-12-month/)
- [Defining High Bleeding Risk in Patients Undergoing Percutaneous Coronary Intervention](https://scholariq.org/papers/defining-high-bleeding-risk-in-patients-undergoing-percutaneous-coronary-2/)
- [JCS 2017/JHFS 2017 Guideline on Diagnosis and Treatment of Acute and Chronic Heart Failure　― Digest Version ―](https://scholariq.org/papers/jcs-2017-jhfs-2017-guideline-on-diagnosis-and-treatment-of-acute-and-chronic/)
- [Increased MicroRNA-1 and MicroRNA-133a Levels in Serum of Patients With Cardiovascular Disease Indicate Myocardial Damage](https://scholariq.org/papers/increased-microrna-1-and-microrna-133a-levels-in-serum-of-patients-with/)
- [Defining high bleeding risk in patients undergoing percutaneous coronary intervention: a consensus document from the Academic Research Consortium for High Bleeding Risk](https://scholariq.org/papers/defining-high-bleeding-risk-in-patients-undergoing-percutaneous-coronary/)
- [JCS 2018 Guideline on Diagnosis and Treatment of Acute Coronary Syndrome](https://scholariq.org/papers/jcs-2018-guideline-on-diagnosis-and-treatment-of-acute-coronary-syndrome/)
- [ST-segment elevation myocardial infarction](https://scholariq.org/papers/st-segment-elevation-myocardial-infarction/)
- [JCS/JSCS/JATS/JSVS 2020 Guidelines on the Management of Valvular Heart Disease](https://scholariq.org/papers/jcs-jscs-jats-jsvs-2020-guidelines-on-the-management-of-valvular-heart-disease/)
- [Effect of Intensive Statin Therapy on Regression of Coronary Atherosclerosis in Patients With Acute Coronary Syndrome](https://scholariq.org/papers/effect-of-intensive-statin-therapy-on-regression-of-coronary-atherosclerosis-in/)

## University researchers

- [Takeshi Kimura](https://scholariq.org/researchers/takeshi-kimura/)

## University top topics

Showing 8 of 25.

- [Venous Thromboembolism Diagnosis and Management](https://scholariq.org/topics/venous-thromboembolism-diagnosis-and-management/)
- [Atrial Fibrillation Management and Outcomes](https://scholariq.org/topics/atrial-fibrillation-management-and-outcomes/)
- [Cardiac Valve Diseases and Treatments](https://scholariq.org/topics/cardiac-valve-diseases-and-treatments/)
- [Heart Failure Treatment and Management](https://scholariq.org/topics/heart-failure-treatment-and-management/)
- [Acute Myocardial Infarction Research](https://scholariq.org/topics/acute-myocardial-infarction-research/)
- [Coronary Interventions and Diagnostics](https://scholariq.org/topics/coronary-interventions-and-diagnostics/)
- [Antiplatelet Therapy and Cardiovascular Diseases](https://scholariq.org/topics/antiplatelet-therapy-and-cardiovascular-diseases/)
- [Cardiovascular Function and Risk Factors](https://scholariq.org/topics/cardiovascular-function-and-risk-factors/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.